Nkarta 13G Filing Shows Citadel Advisors Reported A 5.4% Stake In The Co As Of December 6, 2024

Benzinga12/14 06:10

Nkarta Opens Enrolment, Receives Clearance for Autoimmune Diseases Therapy Trials

MT Newswires12/05 20:17

Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

Nkarta12/05 13:00

Nkarta to Participate in an Upcoming Investor Conference

Nkarta11/26 13:00

Nkarta Price Target Lowered to $16 From $20 at Mizuho

Yahoo Finance11/22 19:50

Nkarta Is Maintained at Outperform by Mizuho

Dow Jones11/21 21:24